Cargando…

Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy

AIMS: Given the importance of inflammation in the onset and progression of diabetic cardiomyopathy, we investigated the potential protective effects of triptolide, an anti-inflammatory agent, in streptozotocin-induced diabetic rat model and in H9c2 rat cardiac cells exposed to high glucose. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, He-Ling, Liang, Zhong-Shu, Zhang, Rui, Yang, Kan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617021/ https://www.ncbi.nlm.nih.gov/pubmed/23530831 http://dx.doi.org/10.1186/1475-2840-12-50

Ejemplares similares

Triptolide improves systolic function and myocardial energy metabolism of diabetic cardiomyopathy in streptozotocin-induced diabetic rats
por: Liang, Zhongshu, et al.
Publicado: (2015)

Effects of triptolide and methotrexate nanosuspensions on left ventricular remodeling in autoimmune myocarditis rats
por: Li, Wei, et al.
Publicado: (2019)

Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy?
por: Weir-McCall, Jonathan R., et al.
Publicado: (2016)

Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy
por: Tanaka, Hidekazu, et al.
Publicado: (2020)

Left ventricular strain and untwist in hypertrophic cardiomyopathy: Relation to exercise capacity
por: Abozguia, Khalid, et al.
Publicado: (2010)

Risk and predictors of dyssynchrony cardiomyopathy in left bundle branch block with preserved left ventricular ejection fraction
por: Sharma, Sunita, et al.
Publicado: (2020)

Value of three‐dimensional speckle‐tracking imaging in detecting left ventricular systolic function in patients with dilated cardiomyopathy
por: He, Jionghong, et al.
Publicado: (2019)

Left ventricular cavity obliteration: Mechanism of the intracavitary gradient and differentiation from hypertrophic obstructive cardiomyopathy
por: Pollick, Charles, et al.
Publicado: (2020)

Titin‐truncating variants are associated with heart failure events in patients with left ventricular non‐compaction cardiomyopathy
por: Li, Shijie, et al.
Publicado: (2019)

Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function
por: Tülüce, Selcen Yakar, et al.
Publicado: (2016)

Intermittent hypoxia induces beneficial cardiovascular remodeling in left ventricular function of type 1 diabetic rat
por: Akat, Fırat, et al.
Publicado: (2018)

Progressive decay of Ca(2+) homeostasis in the development of diabetic cardiomyopathy
por: Zhao, Shu-Mei, et al.
Publicado: (2014)

Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy
por: van der Merwe, Lize, et al.
Publicado: (2008)

Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: A mini review
por: Ziaei, Samira, et al.
Publicado: (2016)

Impact of myocardial scars on left ventricular deformation in type 2 diabetes mellitus after myocardial infarction by contrast-enhanced cardiac magnetic resonance
por: Gao, Yue, et al.
Publicado: (2021)

Effect of streptozotocin-induced diabetes on left ventricular function in adult rats: an in vivo Pinhole Gated SPECT study
por: Cosyns, Bernard, et al.
Publicado: (2007)

Absence of left bundle branch block and blood urea nitrogen predict improvement in left ventricular ejection fraction in patients with cardiomyopathy and wearable cardioverter defibrillators
por: Mehta, Nikhil A., et al.
Publicado: (2019)

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats
por: Li, Bingong, et al.
Publicado: (2011)

Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle
por: van den Brom, Charissa E, et al.
Publicado: (2010)

Left ventricular noncompaction cardiomyopathy
por: Hawatmeh, Amer, et al.
Publicado: (2017)

Arrhythmogenic left ventricular cardiomyopathy
por: Mirmomen, Seyedeh Mojdeh, et al.
Publicado: (2020)

Arrhythmogenic left ventricular cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2022)

Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment
por: Lu, Jun, et al.
Publicado: (2013)

Impact of overweight on left ventricular function in type 2 diabetes mellitus
por: Suto, Makiko, et al.
Publicado: (2017)

Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat
por: Forcheron, Fabien, et al.
Publicado: (2009)

Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking
por: Zhu, Ning, et al.
Publicado: (2021)

Association of left ventricular longitudinal myocardial function with subclinical right ventricular dysfunction in type 2 diabetes mellitus
por: Todo, Saki, et al.
Publicado: (2021)

Ventricular conduction abnormality in patients with mild to moderate cardiomyopathy
por: Dhande, Mehak, et al.
Publicado: (2023)

Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

Insulin resistance and dysglycemia are associated with left ventricular remodeling after myocardial infarction in non-diabetic patients
por: Yang, Chen Die, et al.
Publicado: (2019)

Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community
por: Somaratne, Jithendra B, et al.
Publicado: (2011)

Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus
por: Mochizuki, Yasuhide, et al.
Publicado: (2015)

Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Effects of puerarin on the pharmacokinetics of triptolide in rats
por: Wang, Qingfa, et al.
Publicado: (2019)

Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways
por: Reinking, Benjamin E, et al.
Publicado: (2009)

Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics
por: Sørensen, Martin H., et al.
Publicado: (2020)

Mid‐ventricular obstruction is associated with non‐sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy
por: Nie, Changrong, et al.
Publicado: (2021)

Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI
por: Yang, Chen Die, et al.
Publicado: (2020)

Left Ventricular Thrombus in Hypertrophic Cardiomyopathy
por: Hamada, Mareomi
Publicado: (2018)

Big endothelin-1 as a clinical marker for ventricular tachyarrhythmias in patients with post-infarction left ventricular aneurysm
por: Ning, Xiaohui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ogc7uqdpb54o8598bgt7jn1t3n